Brentuximab vedotin treatment associated with acute and chronic inflammatory demyelinating polyradiculoneuropathies

Guillaume Fargeot¹, Corinne Dupel-Pottier², Maeva Stephant³, Julien Lazarovici⁴, Laure Thomas⁵, Capucine Mouthon-Reignier⁶, Benramdane Riad⁷, Patrice Carde⁸, Giulia Berzero⁹, Camille Tafani¹⁰, Weiss Nicolas¹¹, Karine Viala¹², Thierry Maisonobe¹², Timothée Lenglet¹², Adrien Wang¹³, Laurent Magy¹⁴, Kevin Bihan¹⁵, Nathalie Gaspar¹⁶, David Adams¹⁷, Andoni Echaniz-Laguna¹⁷, Cecile Cauquil^#³, Dimitri Psimaras^#¹⁸

Affiliations

¹ Department of Neurology, French National Reference Center for Rare Neuropathies, Bicêtre Hospital, AP-HP, Le Kremlin-Bicetre, France guillaume.fargeot@aphp.fr.
² Department of Neurology, Rene Dubos Hospital, Pontoise, Île-de-France, France.
³ Department of Neurology, French National Reference Center for Rare Neuropathies, Bicêtre Hospital, AP-HP, Le Kremlin-Bicetre, France.
⁴ Department of Hematology, Gustave Roussy Institute, Villejuif, France.
⁵ Regional Pharmacovigilance Center, Henri Mondor Hospital, Créteil, France.
⁶ Department of Neurology, Centre Hospitalier Sud Francilien Site Gilles de Corbeil, Corbeil-Essonnes, France.
⁷ Department of Hematology, Rene Dubos Hospital, Pontoise, Île-de-France, France.
⁸ Department of Hematology, Gustave Roussy institute, Paris-Saclay University, Villejuif, France.
⁹ AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Service de Neurologie 2-Mazarin et Université Pierre et Marie Curie-Paris 6, Centre de Recherche de l'Institut du Cerveau et de la Moelle Epinière (CRICM), UMRS 975, Paris 75013, France; Inserm U 975, CNRS, UMR 7225, Paris, France.
¹⁰ Department of Neurology, Military Training Hospital Percy, Service de Santé des Armées, Paris, France, Military Health Service Academy of Val-de-Grâce, Service de Santé des Armées, Paris, France.
¹¹ Département de Neurologie, Unité de Médecine Intensive Réanimation neurologique, Sorbonne Université, Brain Liver Pitié-Salpêtrière (BLIPS) Study Group, INSERM UMR_S 938, Centre de recherche Saint-Antoine, Maladies métaboliques, biliaires et fibro-inflammatoire du foie, Institute of Cardiometabolism and Nutrition (ICAN), AP-HP. Sorbonne Université, Hôpital Pitié-Salpêtrière, Paris, France.
¹² Department of Clinical Neurophysiology, Hôpitaux universitaires Pitié-Salpêtrière-Charles Foix. Assistance Publique Hôpitaux de Paris (APHP), Paris, France.
¹³ Department of Neurology, Foch Hospital, Suresnes, France.
¹⁴ Department of Neurology, National Reference Center for Rare Peripheral Neuropathies, University Hospital, Limoges, France.
¹⁵ Regional Pharmacovigilance Center, Department of Pharmacology, Pitié-Salpêtrière Hospital, AP-HP, Paris, France.
¹⁶ Department of Pediatric and Adolescent Oncology, Gustave Roussy institute, Villejuif, France.
¹⁷ Department of Neurology, French National Reference Center for Rare Neuropathies, Bicêtre Hospital, AP-HP, INSERM U1195 & Paris-Saclay University, Le Kremlin-Bicetre, France.
¹⁸ AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Service de Neurologie 2-Mazarin et Université Pierre et Marie Curie-Paris 6, Centre de Recherche de l'Institut du Cerveau et de la Moelle Epinière (CRICM), UMRS 975, Paris 75013, France; Inserm U 975, CNRS, UMR 7225, Paris 75013, France, Paris, France.

^# Contributed equally.

PMID: 32327451
DOI: 10.1136/jnnp-2020-323124

Brentuximab vedotin treatment associated with acute and chronic inflammatory demyelinating polyradiculoneuropathies

Guillaume Fargeot et al. J Neurol Neurosurg Psychiatry. 2020 Jul.

. 2020 Jul;91(7):786-788.

doi: 10.1136/jnnp-2020-323124. Epub 2020 Apr 23.

Authors

Affiliations

¹ Department of Neurology, French National Reference Center for Rare Neuropathies, Bicêtre Hospital, AP-HP, Le Kremlin-Bicetre, France guillaume.fargeot@aphp.fr.
² Department of Neurology, Rene Dubos Hospital, Pontoise, Île-de-France, France.
³ Department of Neurology, French National Reference Center for Rare Neuropathies, Bicêtre Hospital, AP-HP, Le Kremlin-Bicetre, France.
⁴ Department of Hematology, Gustave Roussy Institute, Villejuif, France.
⁵ Regional Pharmacovigilance Center, Henri Mondor Hospital, Créteil, France.
⁶ Department of Neurology, Centre Hospitalier Sud Francilien Site Gilles de Corbeil, Corbeil-Essonnes, France.
⁷ Department of Hematology, Rene Dubos Hospital, Pontoise, Île-de-France, France.
⁸ Department of Hematology, Gustave Roussy institute, Paris-Saclay University, Villejuif, France.
⁹ AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Service de Neurologie 2-Mazarin et Université Pierre et Marie Curie-Paris 6, Centre de Recherche de l'Institut du Cerveau et de la Moelle Epinière (CRICM), UMRS 975, Paris 75013, France; Inserm U 975, CNRS, UMR 7225, Paris, France.
¹⁰ Department of Neurology, Military Training Hospital Percy, Service de Santé des Armées, Paris, France, Military Health Service Academy of Val-de-Grâce, Service de Santé des Armées, Paris, France.
¹¹ Département de Neurologie, Unité de Médecine Intensive Réanimation neurologique, Sorbonne Université, Brain Liver Pitié-Salpêtrière (BLIPS) Study Group, INSERM UMR_S 938, Centre de recherche Saint-Antoine, Maladies métaboliques, biliaires et fibro-inflammatoire du foie, Institute of Cardiometabolism and Nutrition (ICAN), AP-HP. Sorbonne Université, Hôpital Pitié-Salpêtrière, Paris, France.
¹² Department of Clinical Neurophysiology, Hôpitaux universitaires Pitié-Salpêtrière-Charles Foix. Assistance Publique Hôpitaux de Paris (APHP), Paris, France.
¹³ Department of Neurology, Foch Hospital, Suresnes, France.
¹⁴ Department of Neurology, National Reference Center for Rare Peripheral Neuropathies, University Hospital, Limoges, France.
¹⁵ Regional Pharmacovigilance Center, Department of Pharmacology, Pitié-Salpêtrière Hospital, AP-HP, Paris, France.
¹⁶ Department of Pediatric and Adolescent Oncology, Gustave Roussy institute, Villejuif, France.
¹⁷ Department of Neurology, French National Reference Center for Rare Neuropathies, Bicêtre Hospital, AP-HP, INSERM U1195 & Paris-Saclay University, Le Kremlin-Bicetre, France.
¹⁸ AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Service de Neurologie 2-Mazarin et Université Pierre et Marie Curie-Paris 6, Centre de Recherche de l'Institut du Cerveau et de la Moelle Epinière (CRICM), UMRS 975, Paris 75013, France; Inserm U 975, CNRS, UMR 7225, Paris 75013, France, Paris, France.

^# Contributed equally.

PMID: 32327451
DOI: 10.1136/jnnp-2020-323124

No abstract available

Keywords: haematology; neuromuscular; neuropathy; neurophysiology; oncology.

PubMed Disclaimer

Conflict of interest statement

Competing interests: JL has received research grants and personal fees from Takeda pharmaceutical company. GF, CD-P, MS, LT, CM-R, BR, GB, CT, WN, KV, TM, TL, AW, LM, KB, NG, DA, AE-L, CC and DP declare that they have no conflict of interest.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- HighWire
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Brentuximab vedotin treatment associated with acute and chronic inflammatory demyelinating polyradiculoneuropathies

Affiliations

Brentuximab vedotin treatment associated with acute and chronic inflammatory demyelinating polyradiculoneuropathies

Authors

Affiliations

Conflict of interest statement

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical